Over the past decade, transcatheter mitral valve replacement (TMVR) technologies have
evolved with the objective of improving outcomes for patients with severe mitral regurgitation …

In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Aims This study aimed to compare outcomes after transcatheter mitral valve replacement
(TMVR) and mitral valve transcatheter edge‐to‐edge repair (M‐TEER) for the treatment of …

Background Guideline-directed medical therapy (GDMT) optimization is mandatory before
transcatheter edge-to-edge mitral valve repair (M-TEER) in patients with secondary mitral …

Background: Transcatheter mitral valve replacement (TMVR) is an emerging therapeutic
alternative for patients with secondary mitral regurgitation (MR). Outcomes of TMVR versus …

Background Transcatheter mitral valve replacement (TMVR) using dedicated devices is an
alternative therapy for high-risk patients with symptomatic mitral regurgitation (MR). Aims …

Background Mitral regurgitation (MR) is the most common valvular heart disease worldwide
with a 5-year mortality rate of 50% with medical therapy alone. Several transcatheter mitral …

Abstract Purpose of Review Mitral and tricuspid regurgitation represents a clinical challenge.
They are associated with a poor prognosis, and many patients are not eligible for …

Background Early studies of the Tendyne transcatheter mitral valve replacement (TMVR)
showed promising results in a small selective cohort. Objectives The authors present 1-year …

Background Transcatheter therapies are a recognized alternative intervention in patients
with severe mitral regurgitation who are at high surgical risk. The purpose of this study was …